Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Cheng Shih-Lung

A Review of Omalizumab for the Management of Severe Asthma

Drug Design, Development and Therapy

Pharmaceutical Science

English

Related publications

Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?

European Clinical Respiratory Journal

English

PRS44 Cost Utility Analysis of Omalizumab Therapy for Severe Asthma Patients in Thailand

Value in Health

Occupational Health

English

Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia

Journal of Allergy and Clinical Immunology

English

Lengthening Omalizumab Dosing Interval in Treatment of Moderate to Severe Persistent Asthma

Journal of Allergy and Clinical Immunology

English

Omalizumab as Add‐on Therapy in a Patient With Severe Asthma and OSA

Respirology Case Reports

Respiratory Medicine

English

Omalizumab in the Treatment of Severe Allergic (IgE-mediated) Asthma: An Update on Recent Developments

Clinical and Translational Allergy

Respiratory Medicine

English

Omalizumab and Mepolizumab in the Landscape of Biological Therapy for Severe Asthma in Children: How to Choose?

Italian Journal of Pediatrics

English

Real-Life Effectiveness of Omalizumab in Severe Allergic Asthma Above the Recommended Dosing Range Criteria

English

Efficacy and Safety of Treatment With Biologicals (Benralizumab, Dupilumab, Mepolizumab, Omalizumab and Reslizumab) for Severe Eosinophilic Asthma

Allergy: European Journal of Allergy and Clinical Immunology

English